About this trial
The goal of this clinical investigation is to evaluate visual acuity and contrast sensitivity in low lighting conditions using several different testing devices, and measure nighttime side effects of intraocular lens (IOL) implants after cataract surgery.
Researchers will compare the results for three different types of IOLs to see how each lens contributes to overall visual function, patient experience and satisfaction.
Participants will:
* Complete two different questionnaires about their current vision * Undergo visual testing using several different devices
Eligibility criteria
Qualifiers
Minimum 22 years of age
Bilateral pseudophakia, at least 3 months postoperative from IOL implantation, with one of the study IOL models in at least one eye.
Availability, willingness, and sufficient cognitive awareness to comply with examination procedures
Signed informed consent and HIPAA authorization or equivalent documentation necessary to comply with applicable privacy laws pertaining to medical treatment in the governing countries
Disqualifiers
Any clinically significant pupil abnormalities (non-reactive, fixed pupils, or abnormally shaped pupils.
Inability to focus or fixate for prolonged periods of time (e.g., due to strabismus, nystagmus, etc.)
Uncorrected distance visual acuity worse than 20/25 in either eye
Prior corneal refractive surgery (LASIK, LASEK, RK, PRK, etc.) or intraocular surgery. Note: Prophylactic peripheral iridotomies and peripheral laser retinal repairs that, in the opinion of the investigator will not confound study outcomes are acceptable.
Trial design
Treatments tested in this trial
- None-placebo
Treatment groups
Sponsors and collaborators
Dr. Daniel H. Chang, MD
Lead sponsor
Empire Eye and Laser Center
Sponsor institution
Johnson & Johnson Surgical Vision, Inc.
Collaborator